Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Cardiovascular disease accounts for 70% of deaths in people with diabetes. This is partly due to their abnormal lipoprotein profiles. Several studies have shown that the prescription of statins to this group of people can greatly reduce the risk of death. The National Service Framework for Coronary Heart Disease (NSF for CHD), introduced in March 2000, set targets for treating people at high risk of death from CHD. Our study looked at 14 practices in Surrey to see whether the NSF has had an impact on statin prescribing in people with diabetes over the age of 40. There has been a 21 % increase in the prevalence of diabetes between 1999 and 2002. We have also shown a 74% increase in the prescribing of statins to people with diabetes following the introduction of the NSF for CHD. The increase in the number of people receiving statins has cost implications for primary care trusts. Copyright © 2003 John Wiley & Sons, Ltd.

Original publication




Journal article


Practical Diabetes International

Publication Date





313 - 317